VRCA
Verrica Pharmaceuticals Inc
4.80$
+7.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +1,186.0% | -11.0% | +106.1% | +52.1% | +16.4% | +51.8% | -66.2% | |
| – | +811.1% | +2,645.1% | +48.1% | +194.7% | -38.4% | -17.6% | +188.4% | -50.2% | -53.7% | |
| – | +811.1% | +2,645.1% | +48.1% | +218.7% | -29.4% | -9.2% | – | – | – | |
| – | -170.3% | – | -284.2% | – | -132.7% | – | – | -79.4% | -408.4% | |
| – | +0.0% | +0.0% | -11.9% | +115.5% | -39.9% | -65.8% | +19.9% | -92.5% | -100.0% | |
| – | +0.0% | +0.0% | – | -113.8% | -72.1% | – | -100.7% | -94.8% | – | |
| – | +2,500.0% | +502.9% | -99.5% | +7.1% | +6,230.2% | -6.2% | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | -85.6% | -979.7% | – | -104.7% | +2,235.4% | |
| – | +2,533.3% | +681.3% | -99.6% | +8,229.1% | -4.5% | -150.1% | – | -49.2% | -96.2% | |
| – | – | -80.2% | -164.1% | – | +250.6% | +265.6% | +90.5% | -165.8% | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.